Pune, India

Harshal Jahagirdar

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Pune, IN (2013 - 2020)
  • Maharashtra, IN (2018 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Harshal Jahagirdar: Innovator in Modified Release Formulations

Introduction

Harshal Jahagirdar is a prominent inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of modified release formulations. With a total of 8 patents to his name, Jahagirdar has established himself as a key figure in the industry.

Latest Patents

One of his latest patents is a modified release formulation of lacosamide. This invention provides a formulation that comprises lacosamide and a modified release polymer. The innovative aspect of this formulation is its ability to deliver lacosamide with minimal Cto Cpeak to trough variation over a period of at least 12 hours. This advancement is crucial for improving the therapeutic efficacy of lacosamide in clinical applications.

Career Highlights

Harshal Jahagirdar is currently associated with Lupin, Inc., a leading global pharmaceutical company. His work at Lupin has allowed him to focus on developing advanced drug delivery systems that enhance patient outcomes. His expertise in pharmaceutical sciences has been instrumental in driving innovation within the company.

Collaborations

Some of his notable coworkers include Shirishkumar Kulkarni and Satish Kumar Dalal. Their collaboration has fostered a productive environment for research and development, leading to significant advancements in pharmaceutical formulations.

Conclusion

Harshal Jahagirdar's contributions to the field of modified release formulations exemplify his commitment to innovation in pharmaceuticals. His work continues to impact the industry positively, paving the way for improved therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…